Perbio agrees to $714m takeover by Fisher
Swedish company Perbio Science has agreed to a $714 million (€626m)
takeover by Fisher Scientific International of the USA, which says
that it sees the acquisition as a means of capitalising on the
strong growth of the life science...
Pharma adopts wait-and-see stance on toxicogenomics
The world market for toxicogenomics technologies is set to grow
strongly over the next five years, but needs the catalyst of
recognition by regulatory authorities.
First gene linked to stroke
Researchers from Icelandic genomics company deCODE Genetics have
discovered the first gene ever linked to ischaemic stroke, raising
the hope that new drugs to treat the condition may be developed.
GSK detector sounds good to Akubio
Akubio bolsters its position in acoustic detection, which uses
sound to detect the interactions between molecules, by licensing a
complementary technology from GlaxoSmithKline.
GSK licenses 'bio-adjuvant'
GlaxoSmithKline has secured rights to a technology, developed in
partnership with US company Advaxis, could improve the
effectiveness of vaccine-based treatments for cancer.
Quicker route to conjugate vaccines
Pall tells BIOPHEX/INTERPHEX conference that use of its
ultrafiltration technologies cuts both the time and cost of
conjugate vaccine production; greater adoption could increase the
availability of vaccines for diseases such as meningitis...
New CEO takes charge at Tecan
Switzerland's Tecan has appointed a new CEO, Aitor Galdos, four
months after the abrupt departure of the former post-holder Emile
FtsZ blocker developed at Merck
Researchers at Merck Research Laboratories have discovered a
small-molecule drug that blocks the activity of FtsZ, an emerging
therapeutic target for antibacterial agents.
BioRobotics bought by US firm
Harvard Bioscience expands in Europe by acquiring UK DNA microarray
and colony picking instrument firm BioRobotics for $3.2 million
SBS: new product round-up
New products unveiled as the SBS annual meeting gets underway
include systems for high-throughput screening, genotyping and patch
Explosion at Sigma-Aldrich plant
A production facility operated by Sigma-Aldrich was rocked by a
serious explosion on Monday. There were no casualties, but the
facility itself has been 'largely destroyed'.
Boom expected in cell culture reagents
The US market for media, sera and reagents used in cell culture is
expected to nearly double in value to reach $1.7 billion (€1.48bn)
in 2008, according to a report.
UK benefiting from German reform?
Healthcare reform and cost containment affecting the rest of Europe
are making the UK increasingly attractive to the branded
CRO industry coming under pressure
Contract research organisation (CRO) revenues have been growing
strongly as a result of drug developers' need to reduce R&D
costs while shortening product evaluation times. However, as demand
for more efficient preclinical...
Drug treatment for CJD?
Quinacrine could provide the first drug treatment for
prion-associated disorders such as Creutzfeldt-Jakob disease,
according to new research presented at ICAAC.